Company Aggregate Debt: angiodynamics.com (ANGO)

This chart of AngioDynamics, Inc. (ANGO) share prices on the GURU.Markets platform allows for an analysis of the debt load, which stands at 0.01. The business focuses on creating advanced systems for oncology and vascular therapy, developing the NanoKnife and Auryon brands to drive profitability. Simultaneously, the company adheres to environmental standards by implementing energy saving measures in production and recycling polymer waste.
Metric breakdowns and analytics for AngioDynamics (ANGO)

High plant utilization at AngioDynamics, Inc. (ANGO) and the automation of quality control require significant capital expenditures. These costs directly impact the volume of borrowed funds, shaping the current value of 0.01. This metric aggregates all credit obligations to institutional lenders to assess the debt load. Monitoring this metric allows for the determination of business resilience to rising interest rates. By analyzing the total debt chart, an investor evaluates the balance between financial risks and the pace of expansion.